Cholesterol medications are among the most studied drugs in modern medicine, and for most people, the benefits significantly outweigh the risks. That said, side effects are real, they vary by drug type, and some people genuinely struggle with them. Whether the tradeoff makes sense depends on your cardiovascular risk, the specific medication, and how your body responds.
Muscle Pain: The Most Common Complaint
Muscle aches are the side effect people worry about most with statins, the most widely prescribed class of cholesterol drugs. Reported rates range from 1% to 10% of patients depending on the study. A large Cochrane Review found that about 9.4% of statin users reported muscle symptoms, which can feel like a flu-like soreness or general weakness.
Here’s what makes this tricky: somewhere between 30% and 50% of people who believe their muscle pain is caused by a statin actually experience the same symptoms on a placebo. That doesn’t mean the pain isn’t real. It means non-specific muscle aches are common in the general population (especially among older adults), and it’s genuinely difficult to tell whether the statin is responsible. Researchers have developed structured scoring tools to help clinicians sort this out, but there’s still no perfect test.
If you do experience muscle pain on a statin, the typical approach is switching to a different statin, lowering the dose, or trying a non-statin alternative. Most muscle symptoms resolve once the medication is adjusted.
Rhabdomyolysis: Rare but Serious
The severe version of muscle damage, called rhabdomyolysis, involves actual muscle breakdown that can harm the kidneys. This is the side effect that gets the most alarming headlines, but it’s extremely uncommon. For commonly used statins, the rate is roughly 0.5 cases per 10,000 person-years of use. To put that in context, if 10,000 people took a statin for a full year, fewer than one person would be hospitalized for this condition. One older statin, cerivastatin, had a much higher rate and was pulled from the market in 2001.
Liver Effects Are Mostly Harmless
Statins can cause a bump in liver enzymes in up to 2% of patients. This sounds concerning, but these elevations are almost always harmless. They typically resolve with a dose reduction and aren’t associated with actual liver damage. According to research published through the American Heart Association, asymptomatic liver enzyme rises are not linked to structural changes in liver tissue unless there are signs of more serious dysfunction like elevated bilirubin. Routine liver monitoring is no longer recommended for most statin users because clinically significant liver injury is so rare.
Diabetes Risk: A Real but Modest Tradeoff
Statins do slightly increase the risk of developing type 2 diabetes. Moderate-intensity statins raise the risk by about 11%, and high-intensity statins may increase it by 20% or more compared to taking no statin. This tends to affect people who are already on the borderline, those with prediabetes, higher body weight, or other metabolic risk factors. For someone already at low risk of diabetes, the absolute increase is small. For someone at high cardiovascular risk, the reduction in heart attacks and strokes generally far outweighs a modest uptick in blood sugar.
Memory Loss Concerns
The FDA added a note to statin labels in 2012 about reports of memory loss and confusion. This understandably worried a lot of people. But the FDA’s own review of adverse event reports, observational studies, and clinical trials found that these cognitive symptoms are generally not serious, not common, and reversible once the drug is stopped. Resolution typically happens within about three weeks. Large clinical trials have not found that statins cause meaningful cognitive decline, and systematic reviews do not support a causal link between statins and dementia.
Non-Statin Cholesterol Drugs Have Different Profiles
Not all cholesterol medications are statins. If you can’t tolerate a statin, there are alternatives, each with its own side effect profile.
Bile acid sequestrants (older drugs like cholestyramine) are effective but notoriously hard on the gut. In one major trial, 68% of patients reported at least one gastrointestinal side effect during the first year. Constipation affected 39%, abdominal gas 32%, and heartburn 27%. Compliance was so poor that most patients couldn’t stick with the recommended dose.
Newer options include ezetimibe, which blocks cholesterol absorption in the intestine, and injectable PCSK9 inhibitors. Both have low rates of muscle symptoms, even in patients who previously couldn’t tolerate statins. In head-to-head trials of statin-intolerant patients, PCSK9 inhibitors achieved large cholesterol reductions with no difference in muscle-related side effects compared to ezetimibe. The main downside of PCSK9 inhibitors is that they require injections (typically once or twice monthly) and can cause reactions at the injection site.
How Much Benefit You Get Depends on Your Risk
The question of whether cholesterol medicine is “bad for you” really comes down to the balance between side effects and the cardiovascular events it prevents. That balance shifts dramatically based on your starting risk level.
A large population study measured how many people need to take a statin for five years to prevent one cardiovascular event. For people with the lowest risk (under 5% chance of a heart attack or stroke in 10 years), 470 people needed treatment to prevent one event. For people at higher risk (10% to 20% ten-year risk), that number dropped to just 62. In other words, the higher your risk, the more likely the medication is to directly help you, and the more the benefits tip in your favor relative to any side effects.
The 2026 guidelines from the American College of Cardiology and American Heart Association now recommend considering statin therapy at a predicted 10-year risk as low as 3%, reflecting growing evidence that even people at relatively low risk see a net benefit given how uncommon serious side effects are. For people at borderline risk, a coronary artery calcium scan can help personalize the decision. A score of zero may mean it’s reasonable to hold off on medication and recheck in three to seven years.
Putting It All Together
Cholesterol medications cause side effects in a meaningful minority of users. Muscle aches affect roughly 1 in 10 people (though many of those cases aren’t truly drug-related), liver enzyme bumps occur in about 1 in 50, and diabetes risk rises modestly. Serious complications like rhabdomyolysis are genuinely rare. Cognitive symptoms, when they occur, are reversible.
For people with established heart disease or significant risk factors, the math is strongly in favor of treatment. Statins prevent heart attacks and strokes at rates that far exceed their side effect burden. For people at very low risk, the benefit is smaller and the decision is more personal. The most productive conversation isn’t whether cholesterol medicine is universally “bad” or “good,” but whether the specific benefit it offers you outweighs the specific risks you face.